image
Salarius Pharmaceuticals, Inc. SLRX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.34
-2.9 %
$ 1.93 M
Market Cap
-0.15
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% 99.96% 99.96%
Annual Report FY 10-K 2022-12-31 0.00% -146.96% -148.51%
Annual Report FY 10-K 2021-12-31 -64.84% -79.02% -64.56%
Annual Report FY 10-K 2020-12-31 51.03% -26.52% 18.69%
Annual Report FY 10-K 2019-12-31 313.49% 74.41% 56.62%
Annual Report FY 10-K 2018-12-31 -34.27% 36.34% 36.43%
Annual Report FY 10-K 2017-12-31 26.11% 12.81% 12.94%
Annual Report FY 10-K 2016-12-31 0.00% -35.52% -36.54%
Annual Report FY 10-K 2015-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% 60.20% 60.20%
Quarterly Report Q2 8-K 2024-06-30 0.00% 63.26% 63.05%
Quarterly Report Q1 8-K 2024-03-31 0.00% 67.40% 67.32%
Quarterly Report Q4 8-K 2023-12-31 0.00% 86.40% 85.02%
Quarterly Report Q3 8-K 2023-09-30 0.00% 82.95% -75.32%
Quarterly Report Q2 8-K 2023-06-30 0.00% 17.82% 16.53%
Quarterly Report Q1 8-K 2023-03-31 0.00% 13.69% 11.47%
Quarterly Report Q4 8-K 2022-12-31 100.00% -57.92% -56.33%
Quarterly Report Q3 8-K 2022-09-30 0.00% -283.48% 186.57%
Quarterly Report Q2 8-K 2022-06-30 0.00% -53.47% -29.00%
Quarterly Report Q1 8-K 2022-03-31 0.00% -229.14% -239.30%
Quarterly Report Q4 8-K 2021-12-31 -124.43% -132.24% -28.06%
Quarterly Report Q3 8-K 2021-09-30 0.00% -117.70% -19.44%
Quarterly Report Q2 8-K 2021-06-30 -54.04% -72.31% -24.38%
Quarterly Report Q1 8-K 2021-03-31 12.01% 11.13% 23.84%
Quarterly Report Q4 8-K 2020-12-31 42.38% 6.12% -4.45%
Quarterly Report Q3 8-K 2020-09-30 57.52% 34.67% 32.33%
Quarterly Report Q2 8-K 2020-06-30 654.87% -28.85% -112.08%
Quarterly Report Q1 8-K 2020-03-31 979.12% 6.57% -5.61%
Quarterly Report Q4 8-K 2019-12-31 537.23% 6.28% -53.33%
Quarterly Report Q3 8-K 2019-09-30 248.60% 0.40% -73.82%
Quarterly Report Q2 8-K 2019-06-30 -32.91% 84.70% 84.64%
Quarterly Report Q1 8-K 2019-03-31 -41.22% 72.88% 72.91%
Quarterly Report Q4 8-K 2018-12-31 -42.40% 74.98% 75.03%
Quarterly Report Q3 8-K 2018-09-30 -39.32% 71.73% 71.66%
Quarterly Report Q2 8-K 2018-06-30 -26.83% -2.81% -2.55%
Quarterly Report Q1 8-K 2018-03-31 -26.37% 0.55% 0.76%
Quarterly Report Q4 8-K 2017-12-31 -5.35% -1.63% -1.37%
Quarterly Report Q3 8-K 2017-09-30 -30.96% 12.27% 12.35%
Quarterly Report Q2 8-K 2017-06-30 197.75% 22.52% 22.61%
Quarterly Report Q1 8-K 2017-03-31 0.00% 13.80% 13.92%
Quarterly Report Q4 8-K 2016-12-31 0.00% -0.09% -0.68%
Quarterly Report Q3 8-K 2016-09-30 0.00% -30.48% -31.44%
Quarterly Report Q2 8-K 2016-06-30 0.00% -60.53% -61.69%
Quarterly Report Q1 8-K 2016-03-31 0.00% -59.41% -61.03%
Quarterly Report Q4 8-K 2015-12-31 0.00% -110.93% -111.41%
Quarterly Report Q3 8-K 2015-09-30 0.00% -310.43% -309.73%
Quarterly Report Q2 8-K 2015-06-30 0.00% -223.27% -223.61%
Quarterly Report Q1 8-K 2015-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2014-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2014-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2014-06-30 0.00% 0.00% 0.00%